GPT Healthcare Intrinsic Value
GPTHEALTH Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹26.97 | ₹24.27 - ₹29.67 | -80.0% | Book Value/Share: ₹19.75, P/B: 1.0x |
| Simple DCF (5Y) | dcf | ₹112.06 | ₹89.65 - ₹134.47 | -16.9% | CF Growth: 15.0%, Discount: 15% |
Want to compare with current market value? Check GPTHEALTH share price latest .
Valuation Comparison Chart
GPTHEALTH Intrinsic Value Analysis
What is the intrinsic value of GPTHEALTH?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of GPT Healthcare (GPTHEALTH) is ₹112.06 (median value). With the current market price of ₹134.87, this represents a -16.9% variance from our estimated fair value.
The valuation range spans from ₹26.97 to ₹112.06, indicating ₹26.97 - ₹112.06.
Is GPTHEALTH undervalued or overvalued?
Based on our multi-method analysis, GPT Healthcare (GPTHEALTH) appears to be trading above median value by approximately 16.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.89 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 2.04 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
Related Pages for GPT Healthcare
Additional stock information and data for GPTHEALTH
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2022 | ₹66 Cr | ₹64 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹43 Cr | ₹35 Cr | Positive Free Cash Flow | 8/10 |
| March 2020 | ₹42 Cr | ₹15 Cr | Positive Free Cash Flow | 7/10 |